South & Central America Transfection Reagents and Equipment Market Forecast to 2030
South & Central America Transfection Reagents and Equipment Market Forecast to 2030 – Regional Analysis – by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Economic Burden of Cancer Fuels South & Central America Transfection Reagents and Equipment Market
According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, and it accounted for ~10 million deaths in 2020. As per the International Agency for Research on Cancer, the global cancer burden is likely to increase with the addition of 30.2 million more cases by 2040. According to the Breast Cancer Organization, approximately 5-10% of breast cancer cases worldwide are hereditary and are caused by abnormal genes passed from generations. According to the article “Lifestyle, Genetic Risk and Incidence of Cancer,” published in the International Journal of Epidemiology in 2023, nearly 33% of cancer conditions that occur are hereditary, and the risk of genetic mutations is high in the disease. Hence, people are opting for genetic profiling for the early detection and personalized treatment of hereditary cancer cases. BRCA1 and BRCA2 are sometimes referred to as tumor suppressor genes. People who inherit the harmful variants of one of these genes are at a greater risk of several cancers, most notably breast and ovarian cancer, among other types. These people also tend to develop cancer at younger ages compared to people who do not have variations in the said genes. Studies focused on nucleic acid processing by cancer cells are likely to help understand cancer metabolism. DNA is typically packaged into a viral or non-viral particle to be transferred into the cell that is to be transfected. Gene transfer has been proposed as a new approach to enhance the effectiveness of antitumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to strengthen the antiproliferative effects of classical treatments in lung, colorectal, pancreatic, bladder, and breast cancers, among others. Thus, the elevating economic burden of cancer bolsters the South & Central America transfection reagents and equipment market.
South & Central America Transfection Reagents and Equipment Market Overview
South and Central America region is segmented into Brazil, Argentina, and Rest of South & Central America. Brazil hold more than half of the regional share in the year 2022.
Brazil has made significant developments in the pharmaceutical industry owing to its favorable economic policies and reforms, a solid hold in domestic pharmaceutical production, and elevated healthcare expenditure. As per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America, and it spends 9.1% of its GDP on healthcare. Domestic companies dominate the total production of pharmaceutical products in the country, enabling its trade activities. As per the US Department of Commerce, domestic companies account for ~80% of the total count of pharmaceutical companies in Brazil. Thus, the growing pharmaceutical industry landscape is one of the major factors for Transfection reagents and equipment market growth in Brazil.
Furthermore, Argentina has the largest pharmaceutical industry in South & Central America, after Brazil. The transfection reagents and equipment market growth in the country is widely driven by extensive research and development efforts and growing domestic production of pharmaceuticals. The growing demand for pharmaceutical and biopharmaceutical products due to increasing uncertainties of health conditions, increasingly powerful regulatory environment for the pharmaceutical industry, and improving logistics of raw materials are likely to favor the growth of the transfection reagents and equipment market in Argentina during the forecast period.
South & Central America Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Transfection Reagents and Equipment Market Segmentation
The South & Central America transfection reagents and equipment market is segmented based on product, method, application, end user, and country.
Based on product, the South & Central America transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.
In terms of method, the South & Central America transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
By application, the South & Central America transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.
Based on end user, the South & Central America transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.
Based on country, the South & Central America transfection reagents and equipment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America transfection reagents and equipment market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the South & Central America transfection reagents and equipment market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the South & Central America transfection reagents and equipment market was valued at US$ 55.80 million in 2022 and is expected to reach US$ 99.22 million by 2030, registering a CAGR of 7.5% from 2022 to 2030. Increasing popularity of cell and gene therapy and strategic initiatives by companies are among the critical factors attributed to the South & Central America transfection reagents and equipment market expansion.
Cell and gene therapy manufacturing is a complicated process, which makes its execution and monitoring critical. Advancements in biotechnology have led to the adoption of personalized treatments for the treatment of numerous indications. Cell and gene therapies mostly are used to treat chronic diseases such as neurological disorders, cancer, and genetic disorders. The noteworthy advantages of cell and gene therapy include targeted treatment, faster and more efficient recovery, and reduced side effects. Cell and gene therapies are widely adopted across the world owing to the availability of Food and Drug Administration (FDA) approved products. For instance, the FDA approved an adenovirus ADSTILADRIN manufactured by Ferring Pharmaceuticals A/S in 2022. This recombinant adenovirus (rAd-IFNa/Syn3) delivers human interferon alfa-2b cDNA into the bladder epithelium to treat patients suffering from certain types of bladder cancer. In 2022, CARVYKTI, manufactured by Janssen Biotech, Inc., was also approved by the FDA. CARVYKTI is an autologous CAR-T cell engineered with lentivirus to attack BCMA-expressing tumor cells for the treatment of certain kinds of relapsed or refractory multiple myeloma. Scientists are nowadays employing the transfection technique for the production of these therapies. Hence, an upsurge in the popularity of cell and gene therapy activities fuels the number of transfection procedures performed, which, in turn, fuels the growth of the South & Central America transfection reagents and equipment market.
On the contrary, high cost of instruments and consumables hampers the growth of South & Central America transfection reagents and equipment market.
Based on product, the South & Central America transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held 75.6% share of the South & Central America transfection reagents and equipment market in 2022, amassing US$ 42.18 million. It is projected to garner US$ 75.64 million by 2030 to expand at 7.6% CAGR during 2022-2030.
In terms of method, the South & Central America transfection reagents and equipment market is segmented into viral methods, non viral methods, and hybrid methods. The non-viral methods segment held 57.5% share of the South & Central America transfection reagents and equipment market in 2022, amassing US$ 32.06 million. It is estimated to garner US$ 57.69 million by 2030 to expand at 7.6% CAGR during 2022-2030. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
By application, the South & Central America transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held 52.3% share of South & Central America transfection reagents and equipment market in 2022, amassing US$ 29.19 million. It is predicted to garner US$ 52.63 million by 2030 to expand at 7.6% CAGR during 2022-2030.
Based on end user, the South & Central America transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held 65.8% share of the South & Central America transfection reagents and equipment market in 2022, amassing US$ 36.70 million. It is projected to garner US$ 64.84 million by 2030 to expand at 7.4% CAGR during 2022-2030.
Based on country, the South & Central America transfection reagents and equipment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil held 61.2% share of South & Central America transfection reagents and equipment market in 2022, amassing US$ 34.14 million. It is projected to garner US$ 61.99 million by 2030 to expand at 7.7% CAGR during 2022-2030.
Key players operating in the South & Central America transfection reagents and equipment market are Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Transfection Reagents and Equipment Market – Key Market Dynamics
4.1 South & Central America Transfection Reagents and Equipment Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market – South & Central America Market Analysis
5.1 South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 South & Central America Transfection Reagents and Equipment Market Forecast Analysis
6. South & Central America Transfection Reagents and Equipment Market Analysis – by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Transfection Reagents and Equipment Market Analysis – by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Transfection Reagents and Equipment Market Analysis – by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Transfection Reagents and Equipment Market Analysis – by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Transfection Reagents and Equipment Market -Country Analysis
10.1.1 South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
10.1.1.2 Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Brazil: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Brazil: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Brazil: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Brazil: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Argentina: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Argentina: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Argentina: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Argentina: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.4 Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.4.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.4.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.4.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.4.2.2.1 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.4.2.2.2 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.4.3 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.4.4 Rest of South & Central America: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
Table 1. South & Central America Transfection Reagents and Equipment Market Segmentation
Table 2. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Product
Table 4. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Modality
Table 5. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Viral
Table 6. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Non-Viral
Table 7. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Physical/mechanical Method
Table 8. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Chemical Method
Table 9. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 10. South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by End Users
Table 11. South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 12. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 13. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 14. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 15. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 16. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 17. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 18. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 19. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 20. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 21. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 22. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 23. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 24. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 25. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 26. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 27. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 28. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 29. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 30. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 31. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 32. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 33. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 34. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 35. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
Figure 1. South & Central America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. South & Central America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. South & Central America Transfection Reagents and Equipment Market Share (%) – by Product (2022 and 2030)
Figure 5. Reagents: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. South & Central America Transfection Reagents and Equipment Market Share (%) – by Modality (2022 and 2030)
Figure 8. Viral: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America Transfection Reagents and Equipment Market Share (%) – by Application (2022 and 2030)
Figure 26. Biomedical Research: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Transfection Reagents and Equipment Market Share (%) – by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: South & Central America Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. South & Central America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. South & Central America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Brazil: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Argentina: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of South & Central America: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
The List of Companies – South & Central America Transfection Reagents and Equipment Market
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.